gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · BFRGHealthcarePharmaceuticals

Bullfrog AI Holdings, Inc. Common Stock (BFRG)

$0.5263+0.59%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$0.53▼ 51.72% in range
Nov 4, 2025Low $0.43 · High $1.68Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Bullfrog AI Holdings closed at $0.53 on Nov 4, up 0.59%, 68.7% below its 52-week closing high. Volume of 113.5K shares was 0.07× its 20-day average (below normal).

Split-adjusted performance: -23.6% over one month, -25.4% over six months, -54.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $215.38K, up 547.6% from a year earlier, with a net margin of -636.8%.

Short interest was 1.0M shares at the Oct 15 settlement, up 36.8% from the prior report (6.4% of float, 1.0 days to cover).

Market cap$9.8M18.5M shares
Revenue · quarter$215.4K+547.6% YoY
Diluted EPS$-0.07—
P/E · TTM—P/S 32.7×
Net margin-636.8%Gross 49.6%
Dividend yieldNone
52-week range0.43 – 1.68−68.7% from high
Volume113.5K0.07× 20-day avg
Volatility · 60d135.3%Annualised
Short % of float6.4%1.0 days to cover
Net cash$6.9MCash $6.9M
Next earnings—Not scheduled
Split-adjusted performance
1W +8.0%1M −23.6%3M −10.9%6M −25.4%YTD −40.4%1Y −54.6%3Y −81.3%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum50
Revenue growth94
Net margin27
Value (low P/E)—
Size15

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short1.0M+36.8% vs prior
Days to cover1.0Settled Oct 15
% of float6.4%
Short vol. 10d44.6%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
BFRGBullfrog AI Holdings$0.5263+0.59%−25.4%+547.6%−636.8%—$9.8M
PHIOPhio Pharmaceuticals$0.8699−3.67%−24.4%———$10.1MCompare
ASBPAspire-Lakewood Holdings$7.31+0.55%+31.0%—−2009.6%—$10.3MCompare
TPSTTempest Therapeutics$0.4633−1.13%−77.1%———$9.3MCompare
CALCCalciMedica$1.35−8.50%−56.8%———$9.2MCompare
CURXCuranex Pharmaceuticals$5.80−6.30%−17.7%———$9.1MCompare
ACTUActuate Therapeutics$0.3699+5.69%−87.6%———$8.9MCompare
PTNPalatin Technologies$6.02+15.33%−68.3%—−1449.1%—$10.7MCompare
MTVAMetaVia$1.34+6.35%−4.3%———$8.8MCompare

News about Bullfrog AI Holdings

All news →
BullFrog AI Unveils bfARENAS™ Scenario-based Decision EngineGlobeNewswire Inc. · Mar 25, 2026▲ Positive

Quick answers

What does Bullfrog AI Holdings do?
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects.
What is BFRG's market cap?
$9.76M, based on the Nov 4 close of $0.53.
Does Bullfrog AI Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of BFRG is sold short?
1.0M shares, 6.4% of float, as of Oct 15, 2026.
What sector is BFRG in?
Healthcare, in the Pharmaceuticals industry.

About Bullfrog AI Holdings

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.

HQ: Gaithersburg, MD17 employeesListed Feb 14, 2023bullfrogai.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology